Buenaventura Mining Company Inc – Consensus Indicates Potential 65.5% Upside

DirectorsTalk Interviews

Buenaventura Mining Company Inc with ticker code (BVN) now have 8 analysts in total covering the stock. The consensus rating is ‘Hold’. The range between the high target price and low target price is between 16.86 and 6 with the average target price sitting at 9.93. Now with the previous closing price of 6 this now indicates there is a potential upside of 65.5%. The 50 day moving average now sits at 5.86 and the 200 day MA is 7.94. The company has a market capitalisation of $1,608m. Find out more information at: https://www.buenaventura.com

The potential market cap would be $2,661m based on the market concensus.

Compañía de Minas Buenaventura S.A.A. engages in the exploration, mining development, processing, and trading of precious and base metals. The company explores for gold, silver, lead, zinc, and copper metals. It operates operating mining units, including Tambomayo located in the Caylloma province, Orcopampa Unit located in the province of Castilla, Uchucchacua located in province of Oyón, Julcani located in province of Angaraes, Peru, as well as San Gabrie located in the province of General Sánchez Cerro, in the Moquegua region. The company also owns interests in Colquijirca, La Zanja, Yanacocha, Cerro Verde, El Brocal, Coimolache, Yumpaq, San Gregorio mines, and Trapiche mining unit. In addition, it produces manganese sulphate monohydrate and other by-products generated from minerals; and operates hydroelectric power plants. The company was incorporated in 1953 and is based in Lima, Peru.

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search